Loading ...

Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus

(

precursor to AbATE

)

ITN Protocol #:

ITN017AI

Branded Name:

precursor to AbATE

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Type 1 Diabetes

Current Status:

Withdrawn

Summary:

Evaluation of Tolerability, Safety, and Pharmacokinetics of hOKT3g1

Clinical Operations Manager

NIAID Project Manager

Study Personnel:

Protocol Chair

Kevan Herold, MDkevan.herold@yale.edu

Work: 

203-785-6507

Protocol Chair

Carol Soppecsoppe@immunetolerance.org

Work: 

415-353-4879

Protocol Chair

Peggy Fitzgibbonpeggy.fitzgibbon@nih.gov

Work: 

240-627-3505